Hartford Hospital is an 938-bed acute care teaching hospital located in the South End of Hartford, Connecticut. Hartford Hospital was established in 1854. The hospital campus is located on Seymour Street in Hartford and is directly adjacent to the main campus of the Connecticut Children's Medical Center.

There are 867 beds in Hartford HealthCare.

During the past decade, Hartford HealthCare conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 1 clinical trials were completed, i.e. on average, 4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hartford HealthCare" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 3 trials, followed by "Regeneron Pharmaceuticals" with 2 trials sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored, "Abiomed Inc." with 1 trials sponsored and "Ancora Heart, Inc." with 1 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford HealthCare" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hartford HealthCare" are "Metastatic Cancer" (4 trials), "Melanoma" (3 trials), "Advanced Cancer" (2 trials), "Advanced Melanoma" (2 trials) and "Metastatic Melanoma" (2 trials). Many other conditions were trialed in "Hartford HealthCare" in a lesser frequency.

Most popular intervention types in "Hartford HealthCare" are "Drug" (14 trials), "Device" (5 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "CMP-001" (2 trials), "Nivolumab" (2 trials), "ASP9801" (1 trials) and "AccuCinch Ventricular Restoration System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hartford HealthCare" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hartford HealthCare". undefined are not yet recruiting, 15 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 4 completed trials in Hartford HealthCare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hartford HealthCare, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Hartford HealthCare has several departments that took part in Clinical trials: "Hartford Hospital Cancer Clinical Research Office" - 4 trials